I took it as progress but slow progress. I guess they put a few things on hold pending options response and now the avalanche of things to do has hit them square in the eyes and they are sorting this all out at once:
1. HCV trial follow ups 2. Toxicology studies 3. Making more drug 4. Dual HIV/HCV trial 5. Jetting around to various conferences 6. Bringing in new directors to give clarity 7. Making the drug as a tablet
This is all absolutely critical work. I assume they have enough staff? Timeframe for a deal has been pushed out and I share you concerns, but BIT 225 needs to make its own mark in its own way and then we can see if it flies. I would think we can double the sp this year with some solid news flow, but 12-18-24 months seems to be realistic for "solid" returns. Gotta love the confidence...
BIT Price at posting:
14.5¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)